D Dimer Testing Market Size, Analysis, Share & Forecast 2031
D Dimer Testing Market Size, Analysis, Share & Forecast 2031
Segments - D-dimer Testing Market by Product (Analyzers and Reagents & Consumables), Test Type (Clinical Laboratory Tests and Point-of-care Tests), Testing Method (Enzyme-linked Immunosorbent Assays, Latex-enhanced Immunoturbidimetric Assays, Fluorescence Immunoassays, and Others), Application (Deep Vein Thrombosis, Pulmonary Embolism, Disseminated Intravascular Coagulation, and Others), End-user (Hospitals, Academic & Research Institutes, Diagnostic Centers, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-1428
| 4.5 Rating
| 72 Reviews
| 160 Pages
| Format :
Report Description
The global D-dimer testing market size was USD 1.30 Bn in 2022 and is likely to reach USD 1.85 Bn by 2031, expanding at a CAGR of 4.60% during 2023–2031. The market growth is attributed to the rising demand for advanced point-of-care testing, and increased incidence rate of respiratory and cardiovascular diseases.
D-dimer, also known as fibrin degradation fragment, is a protein fragment that occurs in the bloodstream when fibrinolysis takes place for the breakdown of a blood clot formed when injured.
During the process of fibrinolysis, the clumps present in the blood get broken down; after completion of degradation, the number of clots remains in the blood known as D-dimers. Medical professionals used to carry out elevated d dimer testing by extracting blood samples by using needles to take specimens for further examination to identify the existence of serious blood clots.
D-dimer test is performed when symptoms of blood clotting disorder occurred such as leg pain & swelling, shortness of breathing, nasal congestion, chest pain, and rise in heartbeat, this test is used for diagnosis of various thrombotic disorders such as deep vein thrombosis (DVT) in which clot floats in a deep vein of lower legs followed by other organs of the body.
Pulmonary embolism (PE) is occurred due to obstruction of arteries in the respiratory system and disseminated intravascular coagulation (DIC). As a result, some severe conditions involve the formation of blood clots to a large extent, which can cause organ failure and stroke, due to the obstruction of blood flow to the central nervous system.
The test utilizes monoclonal antibodies of latex particles incorporated in elevated D dimer that increase the molecular weight of the immunocomplexes of the test specimen. The changes observed in the turbidity of the specimen are examined by photometrical analyzers and turbidimetric analyzers.
The market report finds that the COVID-19 pandemic has positively impacted the growth of the global market. The outbreak of the COVID-19 pandemic is creating opportunities for the expansion of the D-dimers market, due to the rising demand of advance diagnostic tools and testing kits.
D Dimer Testing Market Dynamics
The global D-dimer testing market report has up-to-date insights that help in formulating a strategic roadmap about the estimated market scenario and performance during 2023 to 2031.
Drivers
The increasing prevalence of pathophysiological conditions such as various cardiovascular disorders, acute pulmonary syndromes, arterial or venous thromboembolism, cardiac arrhythmias, and acute pancreatitis is a key driver for the rising demand for testing. Moreover, rising demand for advanced point-of-care testing due to lessening the time of treatment and reducing the time of patient stay in the hospital is projected to propel the market growth in the upcoming years. The rising number of geriatric populations who are exposed to severe health risks is expected to boost the market.
Restraints
The presence of heterophilic antibodies prevents the accurate test results of D-dimer testing in the clinical intervention of cardiovascular and pulmonary diseases. This is projected to hinder the market growth in the upcoming years.
Opportunities
The development of aptamers, peptides that bind to a target receptor, lessens the use of antibodies in elevated D dimer testing. These aptamers are offering a higher shelf life of monoclonal antibodies, which can offer profitable opportunities for the market growth.
Scope of D Dimer Testing Market Report
The global D-dimer testing market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
D-dimer Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2020–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Product (Analyzers and Reagents & Consumables), Test Type (Clinical Laboratory Tests and Point-of-care Tests), Testing Method (Enzyme-linked Immunosorbent Assays, Latex-enhanced Immunoturbidimetric Assays, Fluorescence Immunoassays, and Others), Application (Deep Vein Thrombosis, Pulmonary Embolism, Disseminated Intravascular Coagulation, and Others), and End-user (Hospitals, Academic & Research Institutes, Diagnostic Centers, and Others), |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, D Dimer Testing Market Size and Analysis, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
F. Hoffmann-La Roche Ltd; Abbott.; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Laboratory Corporation of America® Holdings.; ARUP Laboratories.; Diazyme Laboratories, Inc.; BIOMÉRIEUX; Sekisui Diagnostics; BioMedica Diagnostics; BD.; Helena Laboratories; and Quidel Corporation. |
D Dimer Testing Market Segment Insights
Based on product, the D-dimer testing market is bifurcated into analyzers and reagents & consumables. The reagents & consumables segment is expected to expand at a significant growth rate during the projection period. The increased selling of reagents and testing kits, the wide accessibility of extemporaneous reagents, and the emergence of highly sophisticated robotic D-dimer assay are the key factors that are expected to expand the segment during the forecast period.
The analyzers segment is anticipated to expand at a rapid pace during the forecast period, owing to a reduction in laboratory time along with increasing clinical research that is expected to augmentation of market growth.
On the basis of test type, the market is classified into clinical laboratory tests and point-of-care tests. The clinical laboratory tests segment is anticipated to constitute a dominant share of the market in the coming years, due to the emergence of highly sophisticated D-dimer assays employed for the diagnosis of disseminated intravascular coagulation.
The point-of-care tests segment is estimated to exhibit robust growth during the forecast period, owing to the introduction of various automated methods. The growth of the segment is attributed to excellent design, improved patient care, lesser maintenance charges, reduced risk of errors, and lesser time of diagnosis. The constant efforts of Research & development to develop fast pace point-of-care tests are estimated to boost the segment growth.
Based on testing method, the D-dimer testing market is classified into enzyme-linked immunosorbent assay (ELISA), latex-enhanced immunoturbidimetric assays, fluorescence immunoassays, and others. The ELISA segment is expected to register a robust growth rate during the forecast period, owing to its high sensitivity towards coagulation biological factors. The emerging automated ELISA assays such as the VIDAS method are expected to propel the segment growth.
The fluorescence immunoassay segment is anticipated to register a high CAGR during the forecast period, due to the rising demand for automated fluorescence immunoassay methods for D-dimer testing. These assays provide accurate results due to their higher sensitivity and employed affordable reagents.
On the basis of application, the market is divided into deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and others. The deep vein thrombosis segment is expected to register a robust CAGR during the forecast period, due to the increasing incidence of deep vein thrombosis with the risk of complications such as difficulty in diagnosis and hindered movement of hospitalized patients. Patients undergone various surgeries are at higher risk of deep vein thrombosis, which simultaneously increases admittance to hospitals and drug treatment. These are the key factors that propel the segment’s growth in the upcoming years.
Based on end-user, the D-dimer testing market is segmented into hospitals, academic & research institutes, diagnostic centers, and others. The hospital’s segment is accounted for a dominant market share, due to the increasing hospital admittance rate of patients along with enhancement in pulmonary embolism cases across the globe.
The diagnostic center’s segment is expected to register vigorous CAGR during the forecast period, due to low-cost diagnosis and treatment provided by diagnostic centers with enhancement in patient satisfaction.
In terms of region, the global D-dimer testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to wide clinical applications of blood clotting testing stimulated by regulatory bodies that involve in the management of coagulation testing.
The Asia Pacific is expected to grow at a rapid pace during the forecast period, owing to government initiatives for awareness of coagulation tests. These initiatives help medical professionals, which ultimately causes an increased demand for d-dimer tests in the region.
Segments
The global D-dimer testing market has been segmented on the basis of
Products
- Analyzers
- Reagents & Consumables
Test Types
- Clinical Laboratory Tests
- Point-of-care Tests
Testing Methods
- Enzyme-linked Immunosorbent Assays
- Latex-enhanced Immunoturbidimetric Assays
- Fluorescence Immunoassays
- Others
Applications
- Deep Vein Thrombosis
- Pulmonary Embolism
- Disseminated Intravascular Coagulation
- Others
End-users
- Hospitals
- Academic & Research Institutes
- Diagnostic Centers
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- F. Hoffmann-La Roche Ltd
- Abbott.
- Siemens Healthcare GmbH
- Bio-Rad Laboratories, Inc.
- Laboratory Corporation of America® Holdings.
- ARUP Laboratories.
- Diazyme Laboratories, Inc.
- BIOMÉRIEUX
- Sekisui Diagnostics
- BioMedica Diagnostics
- BD.
- Helena Laboratories
- Quidel Corporation.
Competitive Landscape
Key players competing in the global D-dimer testing market are F. Hoffmann-La Roche Ltd; Abbott.; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Laboratory Corporation of America® Holdings.; ARUP Laboratories.; Diazyme Laboratories, Inc.; BIOMÉRIEUX; Sekisui Diagnostics; BioMedica Diagnostics; BD.; Helena Laboratories; and Quidel Corporation.
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide.
- In April 2019, Diazyme Laboratories introduced its D-dimer assay technique to expand its testing operation.
Frequently Asked Questions
The global D-dimer testing market size was valued at around USD 1.30 billion in 2022 and is likely to reach USD 1.85 billion by 2031.
The global D-dimer testing market is estimated to register a compound annual growth rate (CAGR) of around 4.60% during the forecast period.
For region analysis, North America dominates the global D-dimer testing market during the forecast period.
Some of the key global D-dimer testing market players are F. Hoffmann-La Roche Ltd; Abbott.; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Laboratory Corporation of America® Holdings.; ARUP Laboratories.; Diazyme Laboratories, Inc.; BIOMÉRIEUX; Sekisui Diagnostics; BioMedica Diagnostics; BD.; Helena Laboratories; and Quidel Corporation.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. D-dimer Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. D-dimer Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. D-dimer Testing Market - Supply Chain
4.5. Global D-dimer Testing Market Forecast
4.5.1. D-dimer Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. D-dimer Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. D-dimer Testing Market Absolute $ Opportunity
5. Global D-dimer Testing Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. D-dimer Testing Market Size and Volume Forecast by Applications
5.3.1. Deep Vein Thrombosis
5.3.2. Pulmonary Embolism
5.3.3. Disseminated Intravascular Coagulation
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global D-dimer Testing Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. D-dimer Testing Market Size and Volume Forecast by End Users
6.3.1. Hospitals
6.3.2. Academic & Research Institutes
6.3.3. Diagnostic Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global D-dimer Testing Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. D-dimer Testing Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global D-dimer Testing Demand Share Forecast, 2019-2026
8. North America D-dimer Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America D-dimer Testing Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America D-dimer Testing Market Size and Volume Forecast by Applications
8.4.1. Deep Vein Thrombosis
8.4.2. Pulmonary Embolism
8.4.3. Disseminated Intravascular Coagulation
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America D-dimer Testing Market Size and Volume Forecast by End Users
8.7.1. Hospitals
8.7.2. Academic & Research Institutes
8.7.3. Diagnostic Centers
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America D-dimer Testing Demand Share Forecast, 2019-2026
9. Latin America D-dimer Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America D-dimer Testing Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America D-dimer Testing Market Size and Volume Forecast by Applications
9.4.1. Deep Vein Thrombosis
9.4.2. Pulmonary Embolism
9.4.3. Disseminated Intravascular Coagulation
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America D-dimer Testing Market Size and Volume Forecast by End Users
9.7.1. Hospitals
9.7.2. Academic & Research Institutes
9.7.3. Diagnostic Centers
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America D-dimer Testing Demand Share Forecast, 2019-2026
10. Europe D-dimer Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe D-dimer Testing Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe D-dimer Testing Market Size and Volume Forecast by Applications
10.4.1. Deep Vein Thrombosis
10.4.2. Pulmonary Embolism
10.4.3. Disseminated Intravascular Coagulation
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe D-dimer Testing Market Size and Volume Forecast by End Users
10.7.1. Hospitals
10.7.2. Academic & Research Institutes
10.7.3. Diagnostic Centers
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe D-dimer Testing Demand Share Forecast, 2019-2026
11. Asia Pacific D-dimer Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific D-dimer Testing Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific D-dimer Testing Market Size and Volume Forecast by Applications
11.4.1. Deep Vein Thrombosis
11.4.2. Pulmonary Embolism
11.4.3. Disseminated Intravascular Coagulation
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific D-dimer Testing Market Size and Volume Forecast by End Users
11.7.1. Hospitals
11.7.2. Academic & Research Institutes
11.7.3. Diagnostic Centers
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific D-dimer Testing Demand Share Forecast, 2019-2026
12. Middle East & Africa D-dimer Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa D-dimer Testing Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa D-dimer Testing Market Size and Volume Forecast by Applications
12.4.1. Deep Vein Thrombosis
12.4.2. Pulmonary Embolism
12.4.3. Disseminated Intravascular Coagulation
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa D-dimer Testing Market Size and Volume Forecast by End Users
12.7.1. Hospitals
12.7.2. Academic & Research Institutes
12.7.3. Diagnostic Centers
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa D-dimer Testing Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global D-dimer Testing Market: Market Share Analysis
13.2. D-dimer Testing Distributors and Customers
13.3. D-dimer Testing Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. F. Hoffmann-La Roche Ltd
13.4.2. Abbott.
13.4.3. Siemens Healthcare GmbH
13.4.4. Bio-Rad Laboratories, Inc.
13.4.5. Laboratory Corporation of America® Holdings.
13.4.6. ARUP Laboratories.
13.4.7. Diazyme Laboratories, Inc.
13.4.8. BIOMÉRIEUX
13.4.9. Sekisui Diagnostics
13.4.10. BioMedica Diagnostics
13.4.11. BD.
13.4.12. Helena Laboratories
13.4.13. Quidel Corporation.
Methodology
Related Reports
Some other reports from this category!
Our Clients
